Lomond Therapeutics’ $20 Million Private Investment Financing

Snell & Wilmer represented Lomond Therapeutics Holdings, Inc. in the transaction.Lomond Therapeutics Holdings, Inc. (“Lomond Therapeutics”), a clinical-stage biotechnology company, announced the addition of two new…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here